Results 31 to 40 of about 183 (86)

Systematic Review of Health‐Related Quality of Life Impact in Juvenile Localized Scleroderma

Arthritis Care &Research, Volume 76, Issue 3, Page 340-349, March 2024.
Objective The prevalence and types of psychosocial complications of juvenile localized scleroderma (JLS), also known as morphea, an inflammatory and sclerosing disease involving the skin, fascia, muscle, and bone, are poorly understood. Methods We performed a systematic review of literature published between 2000 and 2020 in PubMed, EMBASE, the ...
Luis F. Sanchez‐Espino, Nadia Luca, Elena Pope, Ronald M. Laxer, Andrea M. Knight, Cathryn Sibbald   +5 more
wiley   +1 more source

Novel multispectral imaging to predict disease progression in pediatric morphea

Pediatric Dermatology, Volume 41, Issue 2, Page 229-233, March/April 2024.
Abstract Background Morphea, or localized scleroderma, is an inflammatory, fibrosing skin disorder that can be progressive and debilitating. Infrared thermography frequently has false positive results. The aim of this study was to assess the ability of multispectral imaging to predict disease progression in children with morphea.
Cathal O'Connor, Siobhan McCarthy, Lisa Kiely, Michael A. P. McAuliffe, Mary Bennett   +4 more
wiley   +1 more source

Global research status of localised scleroderma reported over the period 1993–2022: A 30‐year bibliometric analysis

International Wound Journal, Volume 21, Issue 1, January 2024.
Abstract Localised scleroderma predominantly affects the skin with an unknown aetiology. Despite its clinical importance, no comprehensive bibliometric analysis has been conducted to assess the existing research landscape and future prospects for localised scleroderma. The articles related to localised scleroderma were retrieved from the WoSCC database
Zi‐Ming Li, Tian‐Hao Li, Zhu‐Jun Li, Li‐Quan Wang, Xiao Long, Jiu‐Zuo Huang   +5 more
wiley   +1 more source

Bony Hyperplasia Beneath Atrophic Soft Tissue: A Rare Case of En Coup de Sabre and Literature Review. [PDF]

Clin Cosmet Investig Dermatol, 2023
Ma X, Huang J, Chen Y, Wang X, Long X.
europepmc   +1 more source

Successful Treatment of Paediatric Morphea with Tofacitinib. [PDF]

Acta Derm Venereol, 2023
Tang JC, Zheng WY, Han GM, Liu SF, Yang B.   +4 more
europepmc   +1 more source

Concentrations of metalloproteinase-1 in patients with morphea treated with phototherapy: a preliminary study. [PDF]

Postepy Dermatol Alergol, 2022
Malewska-Woźniak A, Lodyga M, Adamski Z.   +2 more
europepmc   +1 more source

Effectiveness of PUVA vs. UVA1 phototherapy in the treatment of morphea patients. [PDF]

Postepy Dermatol Alergol, 2022
Malewska-Woźniak A, Osmola-Mañkowska A, Adamski Z.   +2 more
europepmc   +1 more source

Connective tissue nevus misdiagnosed as juvenile localized scleroderma. [PDF]

Pediatr Rheumatol Online J, 2023
Tirelli F, Giraudo C, Soliani M, Calabrese F, Martini G, Gisondi P, Meneghel A, Zulian F.   +7 more
europepmc   +1 more source

Baricitinib improved morphoea manifestations in a patient with alopecia areata universalis. [PDF]

Skin Health Dis
Rubino V, Baffa ME, Pipitò C, Savian S, Senatore S, Maglie R, Antiga E.   +6 more
europepmc   +1 more source

Treatment Response of Morphea Patients Referred to a Tertiary Dermatology Hospital: A Three-Year Cohort Study. [PDF]

Health Sci Rep
Kianfar N, Babaahmadi M, Dasdar S, Vahabi SM, Ghiasvand K, Aryanian Z, Ansari MS, Etesami I.   +7 more
europepmc   +1 more source